PCVX

NASDAQ 已收盘

Vaxcyte

58.36 USD
▼-0.16-0.27%
盘后 59.00 +1.10%
2026-11-19
市值
$9.09B
市盈率
—
EPS
-8.07
股息率
—
52 周区间
42.40 – 90.75
成交量
982.10K
Beta
1.29
目标价
116.40
52W 低 42.4052W 高 90.75
价格走势

公司简介

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused b...

关联新闻